2025-04-012026-03-312026-03-31false09018329LONGLANE SURGERY LTD2026-11-03falseiso4217:GBPxbrli:pure090183292025-03-31090183292026-03-31090183292025-04-012026-03-31090183292024-03-31090183292025-03-31090183292024-04-012025-03-3109018329bus:SmallEntities2025-04-012026-03-3109018329bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3109018329bus:FullAccounts2025-04-012026-03-3109018329bus:PrivateLimitedCompanyLtd2025-04-012026-03-3109018329core:WithinOneYear2026-03-3109018329core:AfterOneYear2026-03-3109018329core:WithinOneYear2025-03-3109018329core:AfterOneYear2025-03-3109018329core:ShareCapital2026-03-3109018329core:SharePremium2026-03-3109018329core:RevaluationReserve2026-03-3109018329core:OtherReservesSubtotal2026-03-3109018329core:RetainedEarningsAccumulatedLosses2026-03-3109018329core:ShareCapital2025-03-3109018329core:SharePremium2025-03-3109018329core:RevaluationReserve2025-03-3109018329core:OtherReservesSubtotal2025-03-3109018329core:RetainedEarningsAccumulatedLosses2025-03-3109018329core:LandBuildings2026-03-3109018329core:PlantMachinery2026-03-3109018329core:Vehicles2026-03-3109018329core:FurnitureFittings2026-03-3109018329core:OfficeEquipment2026-03-3109018329core:NetGoodwill2026-03-3109018329core:IntangibleAssetsOtherThanGoodwill2026-03-3109018329core:ListedExchangeTraded2026-03-3109018329core:UnlistedNon-exchangeTraded2026-03-3109018329core:LandBuildings2025-03-3109018329core:PlantMachinery2025-03-3109018329core:Vehicles2025-03-3109018329core:FurnitureFittings2025-03-3109018329core:OfficeEquipment2025-03-3109018329core:NetGoodwill2025-03-3109018329core:IntangibleAssetsOtherThanGoodwill2025-03-3109018329core:ListedExchangeTraded2025-03-3109018329core:UnlistedNon-exchangeTraded2025-03-3109018329core:LandBuildings2025-04-012026-03-3109018329core:PlantMachinery2025-04-012026-03-3109018329core:Vehicles2025-04-012026-03-3109018329core:FurnitureFittings2025-04-012026-03-3109018329core:OfficeEquipment2025-04-012026-03-3109018329core:NetGoodwill2025-04-012026-03-3109018329core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3109018329core:ListedExchangeTraded2025-04-012026-03-3109018329core:UnlistedNon-exchangeTraded2025-04-012026-03-3109018329core:MoreThanFiveYears2025-04-012026-03-3109018329core:Non-currentFinancialInstruments2026-03-3109018329core:Non-currentFinancialInstruments2025-03-3109018329dpl:CostSales2025-04-012026-03-3109018329dpl:DistributionCosts2025-04-012026-03-3109018329core:LandBuildings2025-04-012026-03-3109018329core:PlantMachinery2025-04-012026-03-3109018329core:Vehicles2025-04-012026-03-3109018329core:FurnitureFittings2025-04-012026-03-3109018329core:OfficeEquipment2025-04-012026-03-3109018329dpl:AdministrativeExpenses2025-04-012026-03-3109018329core:NetGoodwill2025-04-012026-03-3109018329core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3109018329dpl:GroupUndertakings2025-04-012026-03-3109018329dpl:ParticipatingInterests2025-04-012026-03-3109018329dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3109018329core:ListedExchangeTraded2025-04-012026-03-3109018329dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3109018329core:UnlistedNon-exchangeTraded2025-04-012026-03-3109018329dpl:CostSales2024-04-012025-03-3109018329dpl:DistributionCosts2024-04-012025-03-3109018329core:LandBuildings2024-04-012025-03-3109018329core:PlantMachinery2024-04-012025-03-3109018329core:Vehicles2024-04-012025-03-3109018329core:FurnitureFittings2024-04-012025-03-3109018329core:OfficeEquipment2024-04-012025-03-3109018329dpl:AdministrativeExpenses2024-04-012025-03-3109018329core:NetGoodwill2024-04-012025-03-3109018329core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3109018329dpl:GroupUndertakings2024-04-012025-03-3109018329dpl:ParticipatingInterests2024-04-012025-03-3109018329dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3109018329core:ListedExchangeTraded2024-04-012025-03-3109018329dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3109018329core:UnlistedNon-exchangeTraded2024-04-012025-03-3109018329core:NetGoodwill2026-03-3109018329core:IntangibleAssetsOtherThanGoodwill2026-03-3109018329core:LandBuildings2026-03-3109018329core:PlantMachinery2026-03-3109018329core:Vehicles2026-03-3109018329core:FurnitureFittings2026-03-3109018329core:OfficeEquipment2026-03-3109018329core:AfterOneYear2026-03-3109018329core:WithinOneYear2026-03-3109018329core:ListedExchangeTraded2026-03-3109018329core:UnlistedNon-exchangeTraded2026-03-3109018329core:ShareCapital2026-03-3109018329core:SharePremium2026-03-3109018329core:RevaluationReserve2026-03-3109018329core:OtherReservesSubtotal2026-03-3109018329core:RetainedEarningsAccumulatedLosses2026-03-3109018329core:NetGoodwill2025-03-3109018329core:IntangibleAssetsOtherThanGoodwill2025-03-3109018329core:LandBuildings2025-03-3109018329core:PlantMachinery2025-03-3109018329core:Vehicles2025-03-3109018329core:FurnitureFittings2025-03-3109018329core:OfficeEquipment2025-03-3109018329core:AfterOneYear2025-03-3109018329core:WithinOneYear2025-03-3109018329core:ListedExchangeTraded2025-03-3109018329core:UnlistedNon-exchangeTraded2025-03-3109018329core:ShareCapital2025-03-3109018329core:SharePremium2025-03-3109018329core:RevaluationReserve2025-03-3109018329core:OtherReservesSubtotal2025-03-3109018329core:RetainedEarningsAccumulatedLosses2025-03-3109018329core:NetGoodwill2024-03-3109018329core:IntangibleAssetsOtherThanGoodwill2024-03-3109018329core:LandBuildings2024-03-3109018329core:PlantMachinery2024-03-3109018329core:Vehicles2024-03-3109018329core:FurnitureFittings2024-03-3109018329core:OfficeEquipment2024-03-3109018329core:AfterOneYear2024-03-3109018329core:WithinOneYear2024-03-3109018329core:ListedExchangeTraded2024-03-3109018329core:UnlistedNon-exchangeTraded2024-03-3109018329core:ShareCapital2024-03-3109018329core:SharePremium2024-03-3109018329core:RevaluationReserve2024-03-3109018329core:OtherReservesSubtotal2024-03-3109018329core:RetainedEarningsAccumulatedLosses2024-03-3109018329core:AfterOneYear2025-04-012026-03-3109018329core:WithinOneYear2025-04-012026-03-3109018329core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3109018329core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3109018329core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3109018329core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3109018329core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3109018329core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3109018329core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3109018329core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3109018329core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3109018329core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3109018329core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3109018329core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3109018329core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3109018329core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3109018329core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3109018329core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3109018329core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3109018329core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3109018329core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3109018329core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3109018329core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3109018329core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3109018329core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3109018329core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3109018329core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3109018329core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3109018329core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3109018329bus:Director12025-04-012026-03-3109018329bus:Director22025-04-012026-03-3109018329core:FurnitureFittingsToolsEquipment2025-03-3109018329core:FurnitureFittingsToolsEquipment2026-03-3109018329core:FurnitureFittingsToolsEquipment2025-04-012026-03-31

LONGLANE SURGERY LTD

Registered Number
09018329
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

LONGLANE SURGERY LTD
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

ROBBINS, Hanna, Dr
RUSHMAN, Nic Richard, Dr

Registered Address

Ramsay Brown Llp The Brentano Suite
Solar House, 915 High Road
North Finchley
N12 8QJ

Registered Number

09018329 (England and Wales)
LONGLANE SURGERY LTD
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets3244326
244326
Current assets
Debtors4136,533188,210
Cash at bank and on hand188,429210,332
324,962398,542
Creditors amounts falling due within one year5(149,570)(231,273)
Net current assets (liabilities)175,392167,269
Total assets less current liabilities175,636167,595
Provisions for liabilities6(46)(62)
Net assets175,590167,533
Capital and reserves
Called up share capital1,2001,200
Profit and loss account174,390166,333
Shareholders' funds175,590167,533
The financial statements were approved and authorised for issue by the Board of Directors on 3 November 2026, and are signed on its behalf by:
ROBBINS, Hanna, Dr
Director
Registered Company No. 09018329
LONGLANE SURGERY LTD
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings25
2.Average number of employees

20262025
Average number of employees during the year22
3.Tangible fixed assets

Fixtures & fittings

Total

££
Cost or valuation
At 01 April 251,8321,832
At 31 March 261,8321,832
Depreciation and impairment
At 01 April 251,5061,506
Charge for year8282
At 31 March 261,5881,588
Net book value
At 31 March 26244244
At 31 March 25326326
4.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables132,802188,210
Other debtors3,544-
Prepayments and accrued income187-
Total136,533188,210
5.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables138,92953,225
Other creditors2814,794
Accrued liabilities and deferred income10,360173,254
Total149,570231,273
6.Provisions for liabilities

2026

2025

££
Net deferred tax liability (asset)4662
Total4662
7.Related party transactions
Summary of transactions with entities with joint control or significant interest Included within other debtor, is a loan of £3,544 (2025: £Nil) to Archstone Health Ltd which is an entity under common control. Included within other creditors, is a loan of £281 (2025: £4,794) from Longlane Surgery partnership which is an entity under common control.